Prosilio Pharmaceuticals Private Limited

Prosilio Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74999TN2018PTC125144 Incorporated 05 October 2018 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2024
₹3.08 Cr
▼ 10% YoY
Net profit · FY 2024
₹1.89 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹3.12 Lakh
EBITDA margin 1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Prosilio Pharmaceuticals Private Limited

Data last updated:

Prosilio Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC125144. Its GSTIN is 34AAKCP1263B1ZT (Puducherry).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilavoli and Mukeshmani Dhatchayani.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.29/F1 (Old No.12/F1) A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.08 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 0.6%) and EBITDA of ₹3.12 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.

Court records list 2 cases involving the company, including 2 filed against it.

Prosilio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0016229).

Company details

CIN U74999TN2018PTC125144
Registration Number 125144
Incorporation Date 05 October 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-PY-03-0016229

Recognitions & Rankings of Prosilio Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-PY-03-0016229

Contact details

Prosilio Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No.29/F1 (Old No.12/F1) A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Prosilio Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Prosilio Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Prosilio Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Prosilio Pharmaceuticals Private Limited, buy the company report.

Financials of Prosilio Pharmaceuticals Private Limited

FY 2024 filings available

Prosilio Pharmaceuticals Private Limited reported revenue of ₹3.08 Cr (down 10% YoY) for FY 2024.

Revenue · FY 2024
₹3.08 Cr ▼ 10%
Net profit · FY 2024
₹1.89 Lakh margin 0.6%
EBITDA · FY 2024
₹3.12 Lakh margin 1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 42%
5 years · compounded
▲ 33%

Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹3.12 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.89 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Prosilio Pharmaceuticals Private Limited, buy the company report.

Board of directors of Prosilio Pharmaceuticals Private Limited

Prosilio Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
NilavoliDirector27 Jul 20206 Years 3 MonthsCurrent
Mukeshmani DhatchayaniDirector05 Oct 20188 Years 1 MonthsCurrent

Auditor

Prosilio Pharmaceuticals Private Limited is audited by L. ALBERT KARUNAKARAN for the financial year 2023.

Auditor firmFinancial yearFirm registration number
L. ALBERT KARUNAKARANFY 2023216635

Shareholding

The shareholding of Prosilio Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Prosilio Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Prosilio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Prosilio Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
34AAKCP1263B1ZTPuducherryActive29 Jan 2019

To see the full GST registrations and return filing status of Prosilio Pharmaceuticals Private Limited, buy the company report.

Recent activity

Prosilio Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Nilavoli ceased to be Additional Director on 30 Nov 2021.

AGM
Prosilio Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Prosilio Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Nilavoli ceased to be Additional Director.
Appointed
Nilavoli was appointed as Director.
Ceased
Mathivanan Sundaramoorthy ceased to be Director.
Appointed
Mukeshmani Dhatchayani was appointed as Director.
Incorporation
05 Oct 2018
Prosilio Pharmaceuticals Private Limited was registered on 05 Oct 2018 with Roc Chennai & aged 8 years 1 month as per MCA records.

Frequently asked questions

Prosilio Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U74999TN2018PTC125144.

Prosilio Pharmaceuticals has 2 current directors:

The latest financial statements of Prosilio Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Prosilio Pharmaceuticals is 34AAKCP1263B1ZT, registered in Puducherry.

The CIN (Corporate Identification Number) of Prosilio Pharmaceuticals is U74999TN2018PTC125144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Prosilio Pharmaceuticals has 2 court cases on record: 2 filed against it.

Prosilio Pharmaceuticals was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.

Nilavoli ceased to be Additional Director on 30 Nov 2021. Nilavoli was appointed as Director on 27 Jul 2020. Mathivanan Sundaramoorthy ceased to be Director on 10 Oct 2018. Prosilio Pharmaceuticals has 4 board changes on record in total.

Yes, Prosilio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PY-03-0016229).

The registered office of Prosilio Pharmaceuticals is at No.29F1 Old No.12F1 A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094.